Fulgent Genetics HelioLiver

Dec 07, 2021

Fulgent Genetics has announced the commercial launch of its HelioLiver assay. The multi-analyte blood test incorporates cell free DNA methylation patterns and serum protein markers for the detection of hepatocellular carcinoma. The firm said HelioLiver can detect HCC at its earliest stages when lesions are still small.